Vertex reports positive phase 3 results for IgA nephropathy drug

March 9, 2026 4:02 PM

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) announced positive interim results from its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found